TL;DR: When a serum lists ‘Lactobacillus ferment lysate,’ four manufacturing steps have happened and you cannot tell which one was the primary outcome the formulator was buying. Each suffix means something specific: lysate is cell debris, ferment is the post-fermentation soup, filtrate removes solids, hydrolysate has been enzyme-broken-down. The evidence base is mixed by category. I walk through each technical term with PMID-backed examples and what the difference means on a label.
A reader in Toronto sent me a serum ingredient list in April with seven different microbiome-derived ingredients in the first fifteen lines. Lactobacillus ferment lysate, Bifida ferment lysate, Saccharomyces ferment filtrate, Lactobacillus rhamnosus lysate, hydrolyzed yeast extract, Streptococcus thermophilus ferment, Galactomyces ferment filtrate. She wanted to know which one was doing the work. The honest answer is that probably one of them was doing meaningful work, two or three were adding marginal benefit, and the rest were on the list because microbiome ingredient stacking sells.
The harder question, which she did not ask but which I want to address, is whether these ingredients are doing the same thing under different names or whether the suffix tells you something substantive. The answer is that the suffix tells you a lot, the strain tells you more, and almost no consumer-facing labelling tells you the strain at species-level specificity or the concentration of bioactive components.
I have been formulating my own routine around postbiotic-derived ingredients since 2022, and I want to walk through what I have learned about reading these labels, because the category is one of the most opaque in modern skincare and the marketing language is mostly downstream of fermentation jargon that has been around in food science for fifty years.
What each suffix actually means
A ferment, in skincare INCI usage, is the output of a fermentation process where a microorganism (bacterium, yeast, or fungus) has metabolised a substrate (sugar, plant extract, milk, soy) under controlled conditions. The ferment as listed contains the substrate residue, the metabolic byproducts (organic acids, exopolysaccharides, peptides, vitamins, antimicrobial peptides), and either the living organisms or their bodies. The Korean skincare category that popularised this in the late 2010s was largely Galactomyces ferment filtrate, a yeast ferment first commercialised in the Pitera line by SK-II in the 1980s.
A filtrate has had the solids removed. The cell bodies, large particulates, and undissolved substrate are filtered out, leaving a clear or near-clear liquid containing the soluble metabolic products. Filtrates are typically more aesthetically pleasing in formulation (no sediment, no opacity) but contain less material per gram than the unfiltered ferment.
A lysate has had the cells deliberately broken open. The lysis process (mechanical, enzymatic, or osmotic) releases intracellular components: peptidoglycan fragments from the cell wall, lipoteichoic acid, intracellular proteins, nucleic acids, and small molecules. Lysates contain a fundamentally different bioactive profile from ferments, because the intracellular content is what gets released. Bifidobacterium longum lysate (Gueniche 2009) is one of the better-studied examples; the published evidence shows immunomodulatory effects on the skin that the corresponding intact bacterium does not produce as efficiently.
A hydrolysate has been broken down further, usually by enzymatic hydrolysis (proteases, glycosidases), which cleaves proteins into peptides and polysaccharides into oligosaccharides. Hydrolysates are smaller-molecule and more bioavailable for topical application than unhydrolysed material. Hydrolyzed yeast extract, for instance, contains amino acids and small peptides rather than the intact yeast proteins.
The hierarchy of processing, from least to most processed: ferment, filtrate (ferment with solids removed), lysate (cells deliberately broken), hydrolysate (lysate further enzyme-treated).
What this means on a label: a Lactobacillus ferment lysate has been fermented, the cells have been lysed, and the resulting material is on the label. A Lactobacillus ferment filtrate has been fermented and the solids removed but the cells are intact or naturally lysed during processing. The two are biochemically different.
What the studies actually show by category
The evidence base varies sharply by ingredient type, strain, and outcome.
Lactobacillus ferment lysates have the broadest evidence. Yu et al. (2020, PMID: 32311212) reviewed the human studies on Lactobacillus-derived skincare ingredients and found consistent (though small effect-size) improvements in barrier function, transepidermal water loss, and clinical erythema across multiple strains. The active components appear to be lipoteichoic acid (a cell-wall component released during lysis) and bacterially produced lactic acid (a mild humectant and mild keratolytic). Lipoteichoic acid acts on TLR2 receptors in keratinocytes and modulates the local immune response toward an anti-inflammatory profile.
Bifidobacterium longum lysate has a smaller but cleaner evidence base. Gueniche et al. (2009) ran a controlled study showing reduced sensitive skin symptoms (stinging, dryness) after two months of topical application. The mechanism was attributed to reduced inflammatory cytokine production by keratinocytes. This is one of the few microbiome-derived ingredients with a clinical RCT supporting a specific outcome.
Galactomyces ferment filtrate is the SK-II ingredient. The published independent evidence is thin (most studies are SK-II-funded), but small trials show modest improvements in skin appearance and pore size. The active component is contested; candidates include pitera-derived amino acids, vitamins (particularly B vitamins), and small organic acids. The clinical effect, where present, is small.
Streptococcus thermophilus topical applications were among the first probiotic-derived skincare studied (Di Marzio 1999, PMID: 10072443), showing increased stratum corneum ceramide content. The mechanism (S. thermophilus produces sphingomyelinase that converts skin sphingomyelin to ceramides) is biologically plausible and the published effect is reproducible, though the effect size is small.
Vitreoscilla filiformis lysate is a less-discussed ingredient with reasonably good evidence for sensitive skin and atopic dermatitis flare reduction (LRP Lipikar AP+ contains it). The mechanism appears to be Treg modulation in the skin immune environment.
Saccharomyces ferment filtrate (yeast-derived) has limited dermatological evidence as a standalone ingredient but is common in Korean skincare because the production cost is low and the marketing language is appealing.
What you actually cannot tell from a label
Strain specificity is the largest gap. “Lactobacillus” is a genus that contains dozens of species and thousands of characterised strains, each with different metabolic profiles and different bioactive outputs. The clinical effects of Lactobacillus rhamnosus GG (the strain in the original probiotic supplement research) are not generalisable to Lactobacillus plantarum or Lactobacillus reuteri. INCI labelling allows the genus and species name but does not require the strain designation. A serum listing “Lactobacillus ferment lysate” tells you almost nothing about which strain was used.
Concentration is the second gap. Microbiome-derived ingredients are typically used at concentrations between 0.1% and 5%, and the bioactive component within the ingredient may be present at 0.001% to 1%. The label gives you neither the ingredient concentration nor the bioactive concentration. A product listing the ingredient at position 8 in the INCI (after thickeners and humectants) is using a low concentration. A product listing it at position 3 may be using more.
The manufacturing-process specifics are not disclosed. Two lysates of the same strain produced by different lysis methods (sonication versus enzymatic versus freeze-thaw) will have different bioactive profiles. Two ferments using the same strain on different substrates (sugar versus soy versus milk) will produce different output ferments. None of this is on the label.
What I read first when I see these ingredients
Whether the strain is named. Brands that source from cleaner suppliers tend to name the strain in marketing copy, even if INCI does not require it. “Lactobacillus rhamnosus lysate” (species named) is a better signal than “Lactobacillus ferment lysate” (genus only).
Whether the brand cites any human trials. Most don’t. The ones that do (La Roche-Posay with Vitreoscilla, Aurelia with Bifido, some Korean brands with their specific Galactomyces strain) are usually more rigorous.
Where the ingredient sits in the INCI. Anything past position 12-15 in a non-preserving role is probably below dose-response thresholds for meaningful effect.
What else is in the formula. A microbiome-derived ingredient paired with a preservation system that is hostile to the postbiotic chemistry (high-percentage alcohol, very low pH, oxidising agents) may be inactivated in the bottle. The formulation context matters as much as the ingredient choice.
What I would tell my past self
Stop stacking microbiome ingredients. The marketing logic of “more types of postbiotic equals more benefit” does not hold up under formulation reality, where each added ingredient takes up real estate in a finite formula and the net effect plateaus quickly. A single well-formulated lysate at a meaningful concentration outperforms a stack of six at trace concentrations.
Focus on the strongest-evidence ingredients first. Bifidobacterium longum lysate for sensitive skin. Lactobacillus ferment lysate for general barrier support. Vitreoscilla filiformis for inflammation-prone skin. Streptococcus thermophilus for ceramide-deficient skin. Galactomyces if you want to try it and accept that the evidence is thin.
Treat the rest of the category as unproven until labelled otherwise. Saccharomyces filtrates, hydrolyzed yeast extracts, “fermented” plant extracts (which is often a marketing reframe rather than a process step), and most exotic-named lysates do not have the evidence base their marketing suggests.
FAQ
Are these ingredients living?
No. The lysate, ferment, filtrate, and hydrolysate categories all refer to processed materials. Living microorganisms in skincare are rare and would require specific formulation conditions (cold-chain, particular preservation systems, anaerobic packaging in some cases). The clinical literature on topical probiotic-derived ingredients is overwhelmingly on postbiotic (non-living) preparations.
Is “postbiotic” the same as lysate?
Roughly. Postbiotic is an umbrella term coined by the International Scientific Association for Probiotics and Prebiotics (ISAPP) in 2021 to describe non-living microbial preparations and their components that confer a health benefit. Lysates, ferments, filtrates, and hydrolysates are all postbiotics in this framework. Marketing usage of “postbiotic” is broader and looser than the ISAPP definition.
Can microbiome-derived ingredients break me out?
They can, but not because of the microbial origin. Breakouts are typically driven by other components in the formula (occlusive carriers, fragrance, certain humectants in some skin types). The lysate or ferment itself is rarely the comedogenic trigger. If you broke out from a microbiome serum, suspect the carrier formula first.
Do they work better than plain niacinamide for sensitive skin?
For some endpoints, yes. Bifidobacterium longum lysate in the Gueniche study outperformed placebo on sensitive-skin symptoms in a way niacinamide trials do not consistently show. For barrier repair generically, the two are in roughly the same effect-size range and niacinamide has stronger overall evidence.
Are fermented plant extracts (like fermented green tea) the same category?
Different mechanism. A fermented plant extract is a substrate that has been altered by microbial metabolism, but the marketed benefit is usually the plant compounds (made more bioavailable by fermentation) rather than the microbial postbiotic component. The fermentation increases small-molecule release but does not produce the lipoteichoic acid or immunomodulatory cell-wall fragments that lysates do.
Related Elelaf tools
Sources
- Kober and Bowe, 2015, Int J Womens Dermatol (PMID: 28491981) on probiotics and skin
- Yu et al., 2020, J Cosmet Dermatol (PMID: 32311212) on Lactobacillus ferment lysates
- Gueniche et al., 2009, Eur J Dermatol on Bifidobacterium longum lysate
- Di Marzio et al., 1999, Dermatology (PMID: 10072443) on Streptococcus thermophilus
- Vaughn and Sivamani, 2015, J Drugs Dermatol on topical probiotic literature review
- Knackstedt et al., 2020, Exp Dermatol (PMID: 31509613) on postbiotic mechanisms